ProPhase Labs, Inc.
PRPH
$0.3288
-$0.0063-1.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.64% | -67.59% | -80.65% | -98.24% | -91.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.64% | -67.59% | -80.65% | -98.24% | -91.95% |
| Cost of Revenue | -46.38% | -58.59% | -64.38% | -83.74% | -79.25% |
| Gross Profit | 181.44% | -91.24% | -100.96% | -113.47% | -104.04% |
| SG&A Expenses | 9.95% | 6.89% | 13.29% | -26.46% | -23.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.41% | -15.19% | -19.22% | -55.34% | -54.81% |
| Operating Income | 3.00% | -16.60% | -82.04% | -119.89% | -366.71% |
| Income Before Tax | -2.87% | -25.33% | -88.99% | -121.75% | -336.59% |
| Income Tax Expenses | 236.30% | 213.53% | 219.56% | -75.67% | -177.12% |
| Earnings from Continuing Operations | -94.83% | -116.79% | -202.35% | -147.47% | -460.63% |
| Earnings from Discontinued Operations | 535.78% | 848.45% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.55% | -82.79% | -217.98% | -164.97% | -502.61% |
| EBIT | 3.00% | -16.60% | -82.04% | -119.89% | -366.71% |
| EBITDA | 1.14% | -22.40% | -113.86% | -166.36% | -1,138.29% |
| EPS Basic | -31.03% | -58.96% | -168.46% | -144.53% | -464.41% |
| Normalized Basic EPS | 27.52% | 3.14% | -58.08% | -108.28% | -327.76% |
| EPS Diluted | -31.39% | -59.28% | -168.83% | -145.10% | -457.89% |
| Normalized Diluted EPS | 27.52% | 3.14% | -57.79% | -107.76% | -303.74% |
| Average Basic Shares Outstanding | 63.10% | 35.21% | 12.50% | 9.26% | 8.49% |
| Average Diluted Shares Outstanding | 63.10% | 35.21% | 10.37% | 7.16% | -0.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |